DocuSign's 31% Rally Sets Up a High-Expectation Earnings Test

DocuSign heads into its December 3 quarterly report on the back of a 31% one-month rally, carrying the highest analyst earnings revision expectations in years and a roster of institutional buyers who have been adding aggressively.

The driving force behind the re-rating is analyst expectations, not price alone. The forward EPS revision factor, which tracks how sharply analysts have lifted profit forecasts over the past year, registers at 792 on ORTEX's scoring system, an unusually large upward move that indicates the Street has dramatically rebuilt its earnings model for the company. Short-term EPS momentum over both 30 and 90 days is also positive. The composite ORTEX stock score reached 83.6 in late September, lifted almost entirely by the Growth and Momentum pillars. Value remains the soft spot: the ev_ebit factor scores in the 27th percentile, a signal that the re-rating has compressed the margin of safety for buyers entering now.

Positioning, where data is available, tells a moderately cautious but not extreme story. The utilization and days-to-cover factor scores both rank in the 71st percentile, suggesting the borrow market is tighter than average without being in squeeze territory. The short score ranks in the 34th percentile, meaning outright bearish conviction from short sellers is below the midpoint of the universe. With no direct short interest percentage or cost-to-borrow data in this snapshot, the clearest read available is that lenders are not flooding the market with available shares, but bears are not crowding the name either.

The most concrete bullish signal comes from institutional flows. AQR Capital added 4.1 million shares in the quarter ending June, one of the largest single-manager additions in the holder table. Columbia Management Investment Advisers added 2.27 million shares, lifting its position to 6.2 million shares and roughly 3.3% of outstanding stock. BlackRock, the largest holder at 11.2% of shares, added 152,000 shares in the September quarter. These are not passive index flows: AQR and Columbia are active managers whose moves reflect a deliberate decision to increase exposure ahead of what the Street expects will be materially better earnings. Norges Bank trimmed 285,000 shares through June, the only notable seller among the top fifteen holders.

The price action itself is the headline. A 14.6% gain over the past week and a 30.8% one-month move bring DocuSign back into focus after a period when the September note from ORTEX described an earnings miss and weak guidance that had "reignited investor concerns about AI adoption headwinds." The turnaround has been sharp. At the same time, history at this ticker offers a sobering counterpoint: the last reported earnings event produced a 3.7% one-day gain but a near-flat five-day move of 0.6%, suggesting the stock has not consistently sustained post-results momentum.

The December 3 print now carries the weight of a major revision cycle and a month of strong buying. What to watch is whether the reported figures, particularly any commentary on contract lifecycle management adoption and enterprise deal velocity, justify the forward earnings assumptions that have been revised so aggressively upward.